News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,760 Results
Type
Article (47610)
Company Profile (342)
Press Release (709793)
Multimedia
Podcasts (124)
Webinars (20)
Section
Business (213396)
Career Advice (2151)
Deals (36696)
Drug Delivery (119)
Drug Development (83119)
Employer Resources (178)
FDA (17133)
Job Trends (15559)
News (359470)
Policy (33997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2761)
Accelerated approval (34)
Adcomms (28)
Allergies (148)
Alliances (52911)
ALS (175)
Alzheimer's disease (1724)
Antibody-drug conjugate (ADC) (329)
Approvals (17382)
Artificial intelligence (572)
Autoimmune disease (162)
Automation (43)
Bankruptcy (369)
Best Places to Work (11984)
BIOSECURE Act (21)
Biosimilars (194)
Biotechnology (224)
Bladder cancer (163)
Brain cancer (58)
Breast cancer (660)
Cancer (4969)
Cardiovascular disease (414)
Career advice (1819)
Career pathing (37)
CAR-T (299)
CDC (48)
Celiac Disease (2)
Cell therapy (787)
Cervical cancer (36)
Clinical research (70811)
Collaboration (1813)
Company closure (4)
Compensation (1187)
Complete response letters (61)
COVID-19 (2834)
CRISPR (102)
C-suite (899)
Cystic fibrosis (149)
Data (6377)
Decentralized trials (2)
Denatured (51)
Depression (140)
Diabetes (513)
Diagnostics (7086)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (272)
Drug pricing (187)
Drug shortages (30)
Duchenne muscular dystrophy (238)
Earnings (92214)
Editorial (61)
Employer branding (23)
Employer resources (158)
Events (122796)
Executive appointments (1022)
FDA (20348)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1548)
Gene editing (217)
Generative AI (52)
Gene therapy (634)
GLP-1 (995)
Government (4822)
Grass and pollen (7)
Guidances (386)
Healthcare (19700)
HIV (68)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (261)
Immuno-oncology (63)
Indications (119)
Infectious disease (3121)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (124)
Intellectual property (262)
Interviews (332)
IPO (17019)
IRA (51)
Job creations (3931)
Job search strategy (1526)
JPM (64)
Kidney cancer (16)
Labor market (87)
Layoffs (569)
Leadership (34)
Legal (8305)
Liver cancer (93)
Longevity (15)
Lung cancer (667)
Lymphoma (386)
Machine learning (44)
Management (63)
Manufacturing (835)
MASH (166)
Medical device (14562)
Medtech (14620)
Mergers & acquisitions (20760)
Metabolic disorders (1299)
Multiple sclerosis (167)
NASH (17)
Neurodegenerative disease (333)
Neuropsychiatric disorders (91)
Neuroscience (3006)
Neurotech (1)
NextGen: Class of 2026 (6891)
Non-profit (4688)
Now hiring (68)
Obesity (609)
Opinion (287)
Ovarian cancer (168)
Pain (204)
Pancreatic cancer (236)
Parkinson's disease (290)
Partnered (34)
Patents (521)
Patient recruitment (508)
Peanut (60)
People (61564)
Pharmaceutical (73)
Pharmacy benefit managers (29)
Phase 1 (22204)
Phase 2 (31123)
Phase 3 (23127)
Pipeline (5513)
Policy (300)
Postmarket research (2623)
Preclinical (9504)
Press Release (71)
Prostate cancer (245)
Psychedelics (48)
Radiopharmaceuticals (304)
Rare diseases (871)
Real estate (6339)
Recruiting (71)
Regulatory (25438)
Reports (53)
Research institute (2560)
Resumes & cover letters (372)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (152)
Series A (255)
Series B (196)
Service/supplier (14)
Sickle cell disease (100)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (44)
Startups (3908)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (84)
The Weekly (71)
Vaccines (1071)
Venture capital (97)
Weight loss (391)
Women's health (95)
Worklife (18)
Date
Last 7 days (584)
Last 30 days (2326)
Last 365 days (30629)
2026 (4117)
2025 (31084)
2024 (36331)
2023 (41280)
2022 (52525)
2021 (57140)
2020 (55819)
2019 (48595)
2018 (36614)
2017 (33768)
2016 (33440)
2015 (39617)
2014 (33328)
2013 (28467)
2012 (30634)
2011 (31263)
2010 (29259)
Location
Africa (802)
Alabama (87)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (42474)
Australia (7098)
California (11634)
Canada (3347)
China (1136)
Colorado (491)
Connecticut (499)
Delaware (353)
Europe (94032)
Florida (1726)
Georgia (374)
Hawaii (3)
Idaho (64)
Illinois (920)
India (70)
Indiana (538)
Iowa (23)
Japan (446)
Kansas (131)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1418)
Massachusetts (8415)
Michigan (353)
Minnesota (652)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (28)
Nevada (125)
New Hampshire (86)
New Jersey (3090)
New Mexico (31)
New York (3055)
North Carolina (1534)
North Dakota (10)
Northern California (5663)
Ohio (348)
Oklahoma (22)
Oregon (44)
Pennsylvania (2342)
Puerto Rico (25)
Rhode Island (49)
South America (1180)
South Carolina (69)
South Dakota (1)
Southern California (4534)
Tennessee (181)
Texas (1804)
United States (41462)
Utah (350)
Vermont (1)
Virginia (271)
Washington D.C. (82)
Washington State (957)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
757,760 Results for "smiths detection formerly barringer technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medical Care Technologies Inc. Unveils Breakthrough AI for Early Melanoma Detection
September 18, 2025
·
1 min read
Press Releases
Medical Care Technologies Inc. Launches AI Platform for Early Basal Cell Carcinoma Detection
September 22, 2025
·
1 min read
Press Releases
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
February 19, 2026
·
13 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Erik Digman Wiklund, CEO of Circio and Jacob Becraft, Co-founder and CEO of Strand Therapeutics. They discuss how post-COVID, emerging platforms like circular and logic circuit RNA are expanding the field’s therapeutic horizons.
February 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology, doctors can now measure HER2 more precisely to match patients with the best treatments.
February 12, 2026
·
1 min read
·
Jennifer Smith-Parker
FDA
New Approach Methodologies: Redefining Animal Testing Alternatives
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Stacey Adam, PhD, Vice President of Science Partnerships at the Foundation for the National Institutes of Health and Patrick Smith, Senior Vice President, Translational Science at Certara, to discuss the latest regulatory news and the future for new approach methologies (NAMs) development.
December 4, 2025
·
1 min read
·
BioSpace Insights
1 of 75,776
Next
